LNCaP model of human prostatic carcinoma.

1.5k indexed citations
published 1983
Authors
Julius S. HoroszewiczSusan S. LeongElzbieta KawinskiJames P. KarrHannah Rosenthal
Journal
PubMed

In The Last Decade

doi.org/w74600667 →

Countries where authors are citing LNCaP model of human prostatic carcinoma.

Specialization
Citations

This map shows the geographic impact of LNCaP model of human prostatic carcinoma.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LNCaP model of human prostatic carcinoma. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LNCaP model of human prostatic carcinoma. more than expected).

Fields of papers citing LNCaP model of human prostatic carcinoma.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of LNCaP model of human prostatic carcinoma.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the LNCaP model of human prostatic carcinoma..

About LNCaP model of human prostatic carcinoma.

This paper, published in 1983, received 1.5k indexed citations . Written by Julius S. Horoszewicz, Susan S. Leong, Elzbieta Kawinski, James P. Karr, Hannah Rosenthal, T. Ming Chu, E. A. Mirand and G P Murphy covering the research area of Molecular Biology, Physiology and Oncology. It is primarily cited by scholars working on Molecular Biology (789 citations), Pulmonary and Respiratory Medicine (712 citations) and Genetics (286 citations). Published in PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w74600667.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper [19] Receptor-mediated endocytosis of low-density lipoprotein in cultured cellsBreakdown of academic impact, for the paper Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acidBreakdown of academic impact, for the paper Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.Breakdown of academic impact, for the paper Size-controlled silver nanoparticles synthesized over the range 5–100 nm using the same protocol and their antibacterial efficacyBreakdown of academic impact, for the paper eggNOG 4.5: a hierarchical orthology framework with improved functional annotations for eukaryotic, prokaryotic and viral sequencesBreakdown of academic impact, for the paper Bank-specific, industry-specific and macroeconomic determinants of bank profitabilityBreakdown of academic impact, for the paper Nutrition and physical activity guidelines for cancer survivorsBreakdown of academic impact, for the paper Electrochemical oxidation of organic pollutants for the wastewater treatment: direct and indirect processesBreakdown of academic impact, for the paper Understanding the Intersections between Metabolism and Cancer BiologyBreakdown of academic impact, for the paper iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Rankless by CCL
2026